Inventor · disambiguated record
John Lewis
Also filed as: LEWIS JOHN · LEWIS JOHN D · LEWIS JOHN DAVID
8 granted patents·10 pending applications·8 citations·filing 2011–2025
78Inventor score
Files withENTOS PHARMACEUTICALS INC6OISIN BIOTECHNOLOGIES INC4AEGIS LIFE INC3DUNCAN ROY1LAWSON HEALTH RES INSTITUTE1
Top patents by PatentIndex Score
18 records- 0180US11603543B2Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic proteinOISIN BIOTECHNOLOGIES INC·Filed 2019·Granted Mar 14, 2023·2 cites·28 claims
- 0280US10227386B2Recombinant polypeptides for membrane fusion and uses thereofDUNCAN ROY·Filed 2011·Granted Mar 12, 2019·5 cites·13 claims
- 0375US12454557B2Recombinant polypeptides for membrane fusion and uses thereofENTOS PHARMACEUTICALS INC·Filed 2022·Granted Oct 28, 2025·0 cites·16 claims
- 0475US11459362B2Recombinant polypepties for membrane fusion and uses thereofENTOS PHARMACEUTICALS INC·Filed 2019·Granted Oct 4, 2022·1 cites·8 claims
- 0575US2024374520A1Proteolipid vesicles formulated with fusion associated small transmembrane proteinsENTOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0673US2024374760A1Compositions and methods for liver-specific expression of follistatinOISIN BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 0772US2023348937A1Fusogenic lipid nanoparticles for target cell-specific production of a therapeutic protein fusogenic lipid nanoparticles and methods of manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a diseaseOISIN BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 0866US2024398935A1Sars cov-2 vaccines, associated polynucleotides, and methods of useAEGIS LIFE INC·Filed 2024·Application pending·0 cites
- 0966US2024092905A1Dna therapeutic encoding an antibody or antigen binding fragmentAEGIS LIFE INC·Filed 2023·Application pending·0 cites
- 1065US12421514B2Methods for diagnosing and treating metastatic cancerENTOS PHARMACEUTICALS INC·Filed 2021·Granted Sep 23, 2025·0 cites·1 claims
- 1165US2025090653A1Sars cov-2 vaccine, associated polynucleotides, and methods of useAEGIS LIFE INC·Filed 2022·Application pending·0 cites
- 1265US2024189232A1Proteolipid vesicles formulated with fusion associated small transmembrane proteinsENTOS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1362US2025346925A1Fusogenic lipid nanoparticles and methods for the manufacture and use thereof for the target cell-specific production of a therapeutic protein and for the treatment of a diseaseOISIN BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 1454US11236331B2Methods for diagnosing and treating metastatic cancerENTOS PHARMACEUTICALS INC·Filed 2017·Granted Feb 1, 2022·0 cites·2 claims
- 1547US2021048383A1Methods of diagnosing disease using microflow cytometryNANOSTICS INC·Filed 2019·Application pending·0 cites
- 1646US2021268129A1Theranostic Radiophotodynamic Therapy NanoparticlesTHE GOVERNERS OF THE UNIV OF ALBERTA·Filed 2019·Application pending·0 cites
- 1745US9789213B2EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesisLONDON HEALTH SCI CT RES INC·Filed 2013·Granted Oct 17, 2017·0 cites·20 claims
- 1832US9846167B2Method for detecting and monitoring bone lossLAWSON HEALTH RES INSTITUTE·Filed 2014·Granted Dec 19, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when John Lewis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →